Guinan, PD, Vogelzang, NJ, Fremgen, AM (1995) Renal cell carcinoma: tumor size, stage and survival. Members of the Cancer Incidence and End Results Committee. J Urol 153: pp. 901-903Original Articles: Kidney Cancer: Renal Cell Carcinoma: Tumor Size, Stage and Survival[J] . Patrick D. ...
Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening. BMC Genomics. 2017;18(Suppl 6): doi:10.1186/s12864-017-4026-6.Han,G., Zhao,W., Song,X., Ng,P.K.S., Karama,J.A., Jonasch,E., Mills,G.B., Zhao,Z., Ding...
Renal cell carcinoma (RCC) refers to a heterogenous group of cancers that originate in the proximal convoluted tubule of the kidney. The three most common forms of RCC are clear cell RCC, papillary RCC and chromophobe RCC. Latest Research and Reviews ...
MP28-20 KIDNEY CANCER WELLNESS DETERMINANT (KCWD) AN ADJUNCTIVE TOOL TO PREDICT SURVIVAL IN RENAL CELL CARCINOMA 喜欢 0 阅读量: 2 作者:Ahmet,Bindayi,Aaron,Bloch,Zachary,Hamilton,Shreyas,Joshi,Madhumitha,Reddy,Stephen,Ryan,Ryan,Nasseri,Robert,Uzzo,Ithaar,Derweesh ...
Renal cancer articles from across Nature Portfolio Atom RSS Feed Renal cancer refers to all malignancies that occur within the kidney. Subtypes include renal cell carcinoma and Wilms tumours. Related Subjects Renal cell carcinoma Wilms tumour Latest Research and Reviews KDM5C and KDM5D mutations ...
【英文名】renalcellcarcinoma 【别名】adenocarcinomaofkidney;dear-cellcarcinomaofkidney;肾 癌;肾实质癌;肾腺癌;透明细胞癌;hypernephroidcarcinoma;renalcell carcinomaofkidney;肾上腺样癌 【ICD号】C64 【病因和发病机制研究的进展】 1.病因研究进展 2.发病机制研究进展肾细胞癌(renalcellcancer,RCC)是泌尿系统肿...
Kidney Renal Clear Cell Carcinoma (KIRC) accounts for 75% of all renal cancers. Previous study had conflict evidences regarding NR1B2 role in cancer, and its expression and biological role in KIRC remained unclear. Our aims were to characterize the role
kidney cancermassive lymphadenopathyhistiocytosisWe present the case of a 44-year old man, presenting with acute left flank pain and gross haematuria, affected by bilateral renal mass and massive para-aortic and mediastinic lymphadenopathy, highly suspicious for metastatic renal cancer. (c) 2005 ...
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models. Nature 539, 107–111 (2016). Article CAS PubMed PubMed Central Google Scholar Gordan, J. D. et al. HIF-α effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. ...
[44,45,46]. Senescent cells secrete MMP3, which in turn promotes tumor cell invasion and angiogenesis [47]. Furthermore, the SASP facilitates the transition from epithelial to mesenchymal cells, a transformation involved in the progression of metastatic cancer [48]. SASP constituents secreted by ...